logo
← Back to RNS Announcements

INTERNATIONAL BIOTECHNOLOGY TRUST PROPOSALS TO INTRODUCE DIVIDEND PAYMENTS AND A MORE FLEXIBLE INVESTMENT POLICY

Following strong long term performance, the Board of International Biotechnology Trust plc ("International Biotechnology Trust" or the "Company") today announces two proposals which it believes will be of benefit to shareholders and potential investors. These include the introduction of dividend payments and amendments to International Biotechnology Trust's investment policy to allow it to invest in unquoted funds. Both proposals will be subject to shareholder approval at a general meeting to be held on 29 September 2016 at the offices of BNP Paribas Securities Services S.C.A, 10 Harewood Avenue, London NW1 6AA (the "General Meeting").

Published on 9th September 2016

Science background with molecule or atom Abstract structure for Science or medical background
Science background with molecule or atom Abstract structure for Science or medical background

Disclaimer

The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the UK.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).


I do not accept →